Holen Sie sich die Stockscreener-App
1.76
1.15%
0.02
Handel nachbörslich:
1.76
Schlusskurs vom Vortag:
$1.74
Offen:
$1.75
24-Stunden-Volumen:
279.66K
Relative Volume:
0.21
Marktkapitalisierung:
$285.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-274.18M
KGV:
-0.6944
EPS:
-2.5346
Netto-Cashflow:
$-198.33M
1W Leistung:
+9.32%
1M Leistung:
-25.11%
6M Leistung:
+13.55%
1J Leistung:
-84.78%
1-Tages-Spanne:
$1.71
$1.795
1-Wochen-Bereich:
$1.5706
$1.795
52-Wochen-Spanne:
$0.611
$17.19
Neumora Therapeutics Inc Stock (NMRA) Company Profile
Firmenname
Neumora Therapeutics Inc
Sektor
Branche
Telefon
(857) 760-0900
Adresse
260 ARSENAL PLACE, SUITE 1, WATERTOWN
Vergleichen Sie NMRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NMRA
Neumora Therapeutics Inc
|
1.76 | 281.79M | 0 | -274.18M | -198.33M | -2.5346 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-03-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-03-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2025-03-07 | Herabstufung | Stifel | Buy → Hold |
| 2025-01-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-10-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-22 | Eingeleitet | Needham | Buy |
| 2024-07-08 | Eingeleitet | Mizuho | Outperform |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Hold |
| 2023-10-10 | Eingeleitet | BofA Securities | Buy |
| 2023-10-10 | Eingeleitet | Guggenheim | Buy |
| 2023-10-10 | Eingeleitet | JP Morgan | Overweight |
| 2023-10-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-10-10 | Eingeleitet | Stifel | Buy |
| 2023-10-10 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Neumora Therapeutics Inc Aktie (NMRA) Neueste Nachrichten
Neumora Therapeutics Inc. stock prediction for this weekInsider Selling & Weekly High Return Stock Opportunities - Newser
What’s the recovery path for long term holders of Neumora Therapeutics Inc.July 2025 Big Picture & Real-Time Volume Analysis Alerts - Newser
Using economic indicators to assess Neumora Therapeutics Inc. potentialWeekly Profit Report & Free Daily Entry Point Trade Alerts - Newser
Exit strategy if you’re trapped in Neumora Therapeutics Inc.Quarterly Trade Review & Breakout Confirmation Trade Signals - Newser
Can momentum traders help lift Neumora Therapeutics Inc.Market Trend Report & Fast Entry Momentum Alerts - Newser
Short interest data insights for Neumora Therapeutics Inc.Market Performance Summary & Weekly High Conviction Ideas - Newser
Is Neumora Therapeutics Inc. a candidate for recovery playTrade Exit Summary & Daily Growth Stock Tips - Newser
What MACD signals say about Neumora Therapeutics Inc.2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Can Neumora Therapeutics Inc. recover in the next quarter2025 Top Gainers & AI Enhanced Execution Alerts - Newser
T. Rowe Price Investment Management Inc. Sells 2,899,770 Shares of Neumora Therapeutics, Inc. $NMRA - MarketBeat
What the charts say about Neumora Therapeutics Inc. todayMarket Activity Recap & Free Daily Entry Point Trade Alerts - Newser
Key metrics from Neumora Therapeutics Inc.’s quarterly dataMarket Movers & Real-Time Chart Breakout Alerts - Newser
Neumora Therapeutics Inc. stock volume spike explainedJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Technical analysis overview for Neumora Therapeutics Inc. stock - Newser
Relative strength of Neumora Therapeutics Inc. in sector analysisEarnings Risk Summary & Real-Time Volume Spike Alerts - Newser
Real time alert setup for Neumora Therapeutics Inc. performance2025 Market Sentiment & Fast Entry High Yield Tips - Newser
How to build a dashboard for Neumora Therapeutics Inc. stockTrade Performance Summary & AI Optimized Trade Strategies - Newser
Short interest data insights for Neumora Therapeutics IncJuly 2025 Earnings & Fast Entry and Exit Trade Plans - Newser
Published on: 2025-08-25 00:48:16 - Newser
Best data tools to analyze Neumora Therapeutics Inc. stockQuarterly Earnings Summary & Verified Momentum Stock Ideas - Newser
How institutional ownership impacts Neumora Therapeutics Inc. stockEarnings Overview Report & Safe Investment Capital Preservation Plans - Newser
What data driven models say about Neumora Therapeutics Inc.’s futureJuly 2025 Action & Pattern Based Trade Signal System - Newser
Signal strength of Neumora Therapeutics Inc. stock in tech scannersMarket Sentiment Report & Daily Momentum Trading Reports - Newser
Trading Recap: Can Neumora Therapeutics Inc. sustain its profitabilityDividend Hike & Daily Oversold Stock Bounce Ideas - theviewers.co.kr
Understanding Neumora Therapeutics Inc.’s price movementWeekly Investment Report & Entry Point Strategy Guides - Newser
Will Neumora Therapeutics Inc. rebound enough to break even2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Technical Charts Suggest Momentum Shift in Neumora Therapeutics Inc.July 2025 EndofMonth & Fast Gain Swing Alerts - beatles.ru
Will Neumora Therapeutics Inc. stock go up in YEARJuly 2025 Movers & AI Powered Trade Plan Recommendations - sundaytimes.kr
Live Scanner Shows Breakout on Neumora Therapeutics Inc.July 2025 Highlights & Safe Entry Zone Identification - 더경남뉴스
Can Neumora Therapeutics Inc. Outperform Peers After Recent PullbackJuly 2025 Price Swings & Fast Moving Stock Trade Plans - beatles.ru
Volume spikes in Neumora Therapeutics Inc. stock – what they meanWeekly Trading Summary & Stock Portfolio Risk Management - Newser
Is Neumora Therapeutics Inc. on track to beat earningsPortfolio Performance Summary & Weekly Setup with ROI Potential - theviewers.co.kr
Neumora Therapeutics Initiates Phase 1 Study for Schizophrenia Drug NMRA-861 - MSN
Is now the right time to enter Neumora Therapeutics Inc.July 2025 Chart Watch & Detailed Earnings Play Alerts - theviewers.co.kr
Why Neumora Therapeutics Inc. stock attracts strong analyst attention2025 Fundamental Recap & Weekly Setup with ROI Potential - beatles.ru
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Detecting price anomalies in Neumora Therapeutics Inc. with AIJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - Newser
Custom strategy builders for tracking Neumora Therapeutics Inc.2025 Institutional Moves & Weekly Market Pulse Updates - Newser
Finanzdaten der Neumora Therapeutics Inc-Aktie (NMRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):